Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guardant Health's Beginning Cash Position for the quarter that ended in Mar. 2026 was MXN8,826 Mil.
Guardant Health's quarterly Beginning Cash Position
declined
from Sep. 2025 (MXN13,492 Mil) to Dec. 2025 (MXN12,415 Mil) and
declined
from Dec. 2025 (MXN12,415 Mil) to Mar. 2026 (MXN8,826 Mil).
Guardant Health's annual Beginning Cash Position
increased
from Dec. 2023 (MXN2,409 Mil) to Dec. 2024 (MXN23,644 Mil) but then
declined
from Dec. 2024 (MXN23,644 Mil) to Dec. 2025 (MXN11,339 Mil).
Guardant Health Beginning Cash Position Related Terms
Guardant Health Beginning Cash Position Historical Data
* Premium members only.
The historical data trend for Guardant Health's Beginning Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Beginning Cash Position of MXN8,826 Mil mean?
Guardant Health (MEX:GH) has a Beginning Cash Position of MXN8,826 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Guardant Health and its competitors.
Is Guardant Health's Beginning Cash Position too high?
Guardant Health's current Beginning Cash Position is MXN8,826 Mil. Overall, Guardant Health has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Beginning Cash Position compare to LH and DGX?
Guardant Health's Beginning Cash Position of MXN8,826 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Guardant Health and its competitors. Guardant Health's current Beginning Cash Position is MXN8,826 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Based on GuruFocus' analysis, Guardant Health (MEX:GH) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,081.25, compared to a current price of MXN2,590.00 — trading 139.5% above its estimated fair value. The current Beginning Cash Position is MXN8,826 Mil. Guardant Health's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current Beginning Cash Position is MXN8,826 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guardant Health (MEX:GH) Overvalued in 2026?
Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued.
The current stock price of MXN2,590.00 is trading 139.5% above its estimated GF Value™ of MXN1,081.25.
GuruFocus considers Guardant Health to be Significantly Overvalued.
Key valuation signals for MEX:GH:
Beginning Cash Position: MXN8,826 Mil
GF Value™: MXN1,081.25 vs. price of MXN2,590.00 (139.5% above fair value)
No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
13GF Score
Get the complete analysis for MEX:GH
Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GH has been successfully added to your 
